Enterome Bioscience; Vedanta Biosciences Inc.; Osel Inc.; Synlogic Inc.; Second Genome; Seres Therapeutics; Synthetic Biologics Inc.; uBiome Inc.; Metabiomics Corporate; Rebiotix Inc; BiomX; Microbiome Therapeutics LLC; Yakult Honsha Co. Ltd; DuPont; 4D Pharma; BaseClear BV; ViThera Pharmaceuticals; Pharma PLC; Ferring Pharmaceuticals; Evelo Biosciences; LNC Therapeutics; E.I. du Pont de Nemours and Company; Clinical Microbiomics AS; Locus Biosciences; Microbiome Insights Inc.; MR DNA; PureTech Health; Zymo Research Corp.; OptiBiotix Health Plc; Ritter Pharmaceuticals; Assembly Bioscience Inc.